JP4292262B2 - 予後アレルギー試験または予後炎症試験 - Google Patents

予後アレルギー試験または予後炎症試験 Download PDF

Info

Publication number
JP4292262B2
JP4292262B2 JP2000529614A JP2000529614A JP4292262B2 JP 4292262 B2 JP4292262 B2 JP 4292262B2 JP 2000529614 A JP2000529614 A JP 2000529614A JP 2000529614 A JP2000529614 A JP 2000529614A JP 4292262 B2 JP4292262 B2 JP 4292262B2
Authority
JP
Japan
Prior art keywords
protein
ige
allergen
allergy
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000529614A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002502039A5 (enExample
JP2002502039A (ja
Inventor
ヒュー エイ． サンプソン，
Original Assignee
アラタイン セラピューティクス， エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アラタイン セラピューティクス， エルエルシー filed Critical アラタイン セラピューティクス， エルエルシー
Publication of JP2002502039A publication Critical patent/JP2002502039A/ja
Publication of JP2002502039A5 publication Critical patent/JP2002502039A5/ja
Application granted granted Critical
Publication of JP4292262B2 publication Critical patent/JP4292262B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/02—Nutritional disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2000529614A 1998-01-30 1999-01-28 予後アレルギー試験または予後炎症試験 Expired - Fee Related JP4292262B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7317198P 1998-01-30 1998-01-30
US60/073,171 1998-01-30
PCT/US1999/001832 WO1999039211A1 (en) 1998-01-30 1999-01-28 Prognostic allergy or inflammation test

Publications (3)

Publication Number Publication Date
JP2002502039A JP2002502039A (ja) 2002-01-22
JP2002502039A5 JP2002502039A5 (enExample) 2006-03-02
JP4292262B2 true JP4292262B2 (ja) 2009-07-08

Family

ID=22112157

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000529614A Expired - Fee Related JP4292262B2 (ja) 1998-01-30 1999-01-28 予後アレルギー試験または予後炎症試験

Country Status (9)

Country Link
US (1) US6238925B1 (enExample)
EP (2) EP1939628B1 (enExample)
JP (1) JP4292262B2 (enExample)
AT (2) ATE550665T1 (enExample)
AU (1) AU741635B2 (enExample)
CA (1) CA2319317C (enExample)
DE (1) DE69919327D1 (enExample)
ES (2) ES2229673T3 (enExample)
WO (1) WO1999039211A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022050416A1 (ja) * 2020-09-07 2022-03-10 三菱瓦斯化学株式会社 アレルギー疾患の判定方法及び判定システム

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110838C2 (de) * 2001-03-06 2003-04-03 Mlu Halle Wittenberg Verfahren zur Diagnostik von Allergien, Pseudoallergien und Intoleranzen
WO2002073209A2 (de) * 2001-03-10 2002-09-19 Affina Immuntechnik Gmbh Verfahren zur identifikation von immunreaktiven epitopen auf proteinen
RU2214599C2 (ru) * 2001-11-21 2003-10-20 Самарский медицинский институт "РЕАВИЗ" Способ выявления лиц, относящихся к группе риска по развитию аллергических заболеваний
MXPA05011409A (es) * 2003-04-23 2005-12-12 Medarex Inc Composiciones y metodos para la terapia de enfermedad inflamatoria intestinal.
US7662381B2 (en) 2004-06-21 2010-02-16 Medarex, Inc. Interferon alpha receptor 1 antibodies and their uses
US8859210B2 (en) * 2008-10-17 2014-10-14 Mead Johnson Nutrition Company Method for identifying allergenic proteins and peptides
WO2010101255A1 (ja) * 2009-03-05 2010-09-10 味の素株式会社 クローン病診断試薬
EP2478373B1 (en) * 2009-09-14 2019-01-09 Icahn School of Medicine at Mount Sinai Methods for characterizing antibody binding affinity and epitope diversity in food allergy
WO2012135313A1 (en) * 2011-03-28 2012-10-04 University Of Massachusetts Compositions and methods for detecting allergy to a-gal epitopes
EP2841098A4 (en) 2012-04-23 2016-03-02 Allertein Therapeutics Llc NANOPARTICLES FOR THE TREATMENT OF ALLERGIES
EP3760223A1 (en) 2013-04-03 2021-01-06 N-Fold Llc Nanoparticle composition for desensitizing a subject to peanut allergens
KR102202575B1 (ko) 2013-12-31 2021-01-13 삼성전자주식회사 메모리 관리 방법 및 장치
US11215615B2 (en) 2014-04-03 2022-01-04 AllerGenis LLC Peptides, reagents and methods for detecting food allergy
SG11201705102QA (en) 2014-11-14 2017-07-28 Biomerica Inc Compositions, devices, and methods of ibs sensitivity testing
EP3173789A1 (en) * 2015-11-24 2017-05-31 Helmholtz-Zentrum für Infektionsforschung GmbH Method for differentiation of immune response in an individual
JP2019515275A (ja) * 2016-04-26 2019-06-06 バイオメリカ・インコーポレイテッドＢｉｏｍｅｒｉｃａ， Ｉｎｃ． 潰瘍性大腸炎感受性試験の組成物、デバイスおよび方法
US11686733B2 (en) * 2016-05-13 2023-06-27 Applied Medical Enzyme Research Institute Corporation Method for collecting data to predict risk of developing allergies
RU2621312C1 (ru) * 2016-06-15 2017-06-01 Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) Способ прогнозирования формирования толерантности при аллергии к белку коровьего молока у детей раннего возраста
KR102687458B1 (ko) * 2016-06-16 2024-07-24 호유 가부시키가이샤 생선 알레르기의 항원
CN109804247A (zh) 2016-07-08 2019-05-24 拜尔梅里科有限公司 抑郁症敏感测试的组合物、设备以及方法
CN110716055A (zh) * 2019-09-11 2020-01-21 天津医科大学 过敏原特异性免疫球蛋白e致病活性检测试剂盒
US11237164B2 (en) * 2020-04-15 2022-02-01 ProteinSimple Method for measurement of total protein content and detection of protein via immunoassay in a microfluidic device
JP7555788B2 (ja) * 2020-10-30 2024-09-25 アサヒグループホールディングス株式会社 タンパク質の起源種判別方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736362A (en) * 1990-10-26 1998-04-07 The University Of Melbourne Ryegrass pollen allergen
US5567594A (en) * 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
US5480972A (en) * 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
US5558869A (en) * 1992-12-30 1996-09-24 University Of Arkansas Major peanut allergen ara h II
US5939283A (en) * 1992-12-31 1999-08-17 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from dog dander and uses therefor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022050416A1 (ja) * 2020-09-07 2022-03-10 三菱瓦斯化学株式会社 アレルギー疾患の判定方法及び判定システム

Also Published As

Publication number Publication date
ES2383002T3 (es) 2012-06-15
EP1051626B1 (en) 2009-03-18
AU2347899A (en) 1999-08-16
ES2229673T3 (es) 2009-08-04
AU741635B2 (en) 2001-12-06
EP1939628A1 (en) 2008-07-02
ATE550665T1 (de) 2012-04-15
HK1032262A1 (en) 2001-07-13
CA2319317A1 (en) 1999-08-05
DE69919327T2 (de) 2005-03-10
US6238925B1 (en) 2001-05-29
DE69919327D1 (de) 2009-11-26
JP2002502039A (ja) 2002-01-22
EP1939628B1 (en) 2012-03-21
HK1120865A1 (en) 2009-04-09
EP1051626A1 (en) 2000-11-15
ATE426170T1 (de) 2009-04-15
CA2319317C (en) 2006-04-18
WO1999039211A1 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
JP4292262B2 (ja) 予後アレルギー試験または予後炎症試験
Järvinen et al. Specificity of IgE antibodies to sequential epitopes of hen's egg ovomucoid as a marker for persistence of egg allergy
Järvinen et al. B-cell epitopes as a screening instrument for persistent cow's milk allergy
EP2478373B1 (en) Methods for characterizing antibody binding affinity and epitope diversity in food allergy
US20100086939A1 (en) Determination method for allergic disease
US20140154257A1 (en) Materials and methods for diagnosing and treating asthma and dietary Fru-AGEs related disorders including auto-immune and other diseases found to be associated with elevated RAGE. The specification describes methods to identify and make dietary derived advanced glycation end-products, known as Fru-AGEs, Fru-AGE-haptens, and Fru-AGE immune complexes, and to make monoclonal and polyclonal antibodies to this plurality of bio-molecules for use in immunoassays and for use as therapeutic agents
US20090111702A1 (en) Methods of determining allergen response using microarray immunoassay techniques
Lovegrove et al. Transfer of cow's milk beta-lactoglobulin to human serum after a milk load: a pilot study.
KR101510376B1 (ko) 새우 알레르겐, 항새우 알레르겐 항체 및 그의 이용
US20060094073A1 (en) Saliva immunoassay for detection of antibodies for cardiovascular disease
JP5633721B2 (ja) 乳幼児のアレルギー発症を予測するためのデータを提供する方法
US11686733B2 (en) Method for collecting data to predict risk of developing allergies
JP7385302B2 (ja) アナフィラキシーの発症を予測するためのデータを収集する方法
HK1032262B (en) Prognostic allergy or inflammation test
HK1120865B (en) Prognostic allergy test
JP2022096812A (ja) 抗原ポリペプチド
CN101142480A (zh) 测定变态反应的方法
Zamorano et al. Sensitization and allergy to alpha-galactose: Mechanisms and clinical presentation
US7977063B2 (en) Method for determining an allergic response
Bargman Characterization of allergens in almonds (Prunus amygdalus)
Sekerkova et al. Research Article High Prevalence of Neutrophil Cytoplasmic Autoantibodies in Infants with Food Protein-Induced Proctitis/Proctocolitis: Autoimmunity Involvement?

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060111

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060111

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090105

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090202

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20090302

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20090302

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120417

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120417

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130417

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees